The federal Indefinite Delivery Contract (IDC) SPE2DB24D8001 was awarded by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business. The $999,999,999.00 single-award contract covers a wide range of pharmaceutical products, medical supplies, and healthcare equipment to support the medical supply chain operations for the U.S. Armed Forces.
The contract originates from DLA Troop Support Medical's standing solicitation SPE2DH-21-R-0002 for the ECAT Generation V Program, which seeks proposals for commercial medical equipment, accessories, consumables, and medical simulation equipment used by medical professionals. The unrestricted, multi-award IDIQ contract allows DLA to procure these products from manufacturers, distributors, and other designated sources to support their military medical supply programs. The period of performance runs through December 31, 2025.
Generated 9/5/24, 9:09 AM